chr16-15004210-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_015027.4(PDXDC1):c.266G>A(p.Gly89Asp) variant causes a missense change. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015027.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152292Hom.: 0 Cov.: 50
GnomAD3 exomes AF: 0.0000795 AC: 20AN: 251432Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135902
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000445 AC: 65AN: 1461592Hom.: 0 Cov.: 33 AF XY: 0.0000646 AC XY: 47AN XY: 727122
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000656 AC: 10AN: 152410Hom.: 0 Cov.: 50 AF XY: 0.000107 AC XY: 8AN XY: 74532
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.266G>A (p.G89D) alteration is located in exon 5 (coding exon 5) of the PDXDC1 gene. This alteration results from a G to A substitution at nucleotide position 266, causing the glycine (G) at amino acid position 89 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at